tiprankstipranks
Trending News
More News >
Novabay Pharmaceuticals (NBY)
:NBY
US Market

NovaBay Pharma (NBY) Income Statement

Compare
651 Followers

NovaBay Pharma Income Statement

Last quarter (Q1 2025), NovaBay Pharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q1, NovaBay Pharma's net income was $7.67M. See NovaBay Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.78M$ 10.46M$ 14.40M$ 8.42M$ 9.93M
Gross Profit
$ 6.48M$ 6.08M$ 7.78M$ 5.64M$ 5.96M
Operating Expenses
$ 12.32M$ 12.90M$ 15.46M$ 14.51M$ 12.39M
Depreciation and Amortization
$ 381.00K$ 203.00K$ 483.00K$ 119.00K$ 51.00K
EBITDA
$ -5.92M$ -4.80M$ -7.20M$ -8.74M$ -6.38M
Operating Income
$ -5.84M$ -5.00M$ -7.68M$ -8.86M$ -6.43M
Other Income/Expenses
$ -1.37M$ -2.04M$ -2.78M$ 3.04M$ -4.61M
Pretax Income
$ -7.21M$ -9.64M$ -10.61M$ -5.82M$ -11.03M
Net Income
$ -7.22M$ -9.64M$ -16.27M$ -6.56M$ -11.04M
Per Share Metrics
Basic EPS
$ -2.53$ -139.14$ -353.59$ -184.09$ -385.53
Diluted EPS
$ -2.53$ -138.65$ -353.59$ -184.09$ -385.53
Weighted Average Shares Outstanding
3.40M 120.00K 30.00K 31.64K 28.63K
Weighted Average Shares Outstanding (Diluted)
3.40M 120.00K 46.00K 35.63K 28.63K
Currency in USD

NovaBay Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis